<!DOCTYPE html><html lang="en-GB"><head><title> Data Set Publications</title><link rel="stylesheet" href="../../css/style_main.css"><link rel="stylesheet" href="../../css/colour_scheme.css"><script type="text/javascript" src="https://www.google.com/jsapi"></script><script type="text/javascript" src="../Serine%20Peptidase%20Inhibitor%20Kazal-Type%205.js"></script><script>var primary_colour = "#c9002f";</script><script>var secondary_colour = "#FFB612";</script><script type="text/javascript" src="../keyword_history.js"></script></head><body ><div class='header-container'><div class='header width-master' role='banner'><div id="main-logo"><a accesskey="1" title="D2K" href="https://github.com/OllyButters/puma"><img src="../../d2k_logo.png"/></a></div><div class='maintitle' id='maintitle1'><span id='title1'><a href='../../index.html'>ALSPAC -  Data Set Publications</a></span></div></div></div><div id="wrapper" class="width-master"><div id="col1" role="navigation"><!-- navigation object : navigation --><ul class="navgroup"><li><a href="../../index.html">Home</a></li><li><a href="../../help/index.html">About</a></li><li><a href="../../search/index.html">Search</a></li><li><a href="../../all_keywords/index.html">All Keywords</a></li><li><a href="../../major_keywords/index.html">Major Keywords (MeSH)</a></li><li><a href="../../country/index.html">Map by Country</a></li><li><a href="../../institute/index.html">Map by UK institute</a></li><li><a href="../../metrics/index.html">Study Metrics</a></li><li><a href="../../wordcloud/index.html">Major Keyword Cloud</a></li><li><a href="../../abstractwordcloud/index.html">Abstract Word Cloud</a></li><li><a href="../../coverage_report.html">Coverage report</a></li></ul><div class="after-navgroup"><!-- navigation object : navigation bottom --><!-- start navigation : additional logo --></div></div><p id="breadcrumbs"><a href="../../index.html">Home</a> &gt; Keyword &gt; Serine Peptidase Inhibitor Kazal-Type 5</p><div id="content" role="main"><h1 id="pagetitle">Keyword - Serine Peptidase Inhibitor Kazal-Type 5</h1><h2>Keyword History</h2><div id="papers_chart_div"></div><div id="citations_chart_div"></div><h2>Publications</h2><p><em>1 publications with this keyword</em></p><div class="paper"><div style="float:right;" data-badge-popover="right" data-badge-type="donut" data-doi="10.1016/j.jaci.2008.05.050" data-hide-no-mentions="true" class="altmetric-embed"></div><span style="text-decoration: underline; font-weight:bold;">Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk.</span><br/>Weidinger, Stephan; Baurecht, Hansj√∂rg; Wagenpfeil, Stefan; Henderson, John; Novak, Natalija; Sandilands, Aileen; Chen, Huijia; Rodriguez, Elke; O&#x27;Regan, Grainne M; Watson, Rosemarie; Liao, Haihui; Zhao, Yiwei; Barker, Jonathan N W N; Allen, Michael; Reynolds, Nick; Meggitt, Simon; Northstone, Kate; Smith, George D; Strobl, Carolin; Stahl, Caroline; Kneib, Thomas; Klopp, Norman; Bieber, Thomas; Behrendt, Heidrun; Palmer, Colin N A; Wichmann, H-Erich; Ring, Johannes; Illig, Thomas; McLean, W H Irwin; Irvine, Alan D<br/>J. Allergy Clin. Immunol., Volume 122, Issue 3<br/>PMID: <a href="http://www.ncbi.nlm.nih.gov/pubmed/18774391">18774391</a>&nbsp;DOI: <a href="https://doi.org/10.1016/j.jaci.2008.05.050">10.1016/j.jaci.2008.05.050</a>&nbsp;<table class='citation_table'><tr><th colspan="1">Citation Counts</th></tr><tr><td style="width:100.0%;">Scopus: <a href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=50649101129&origin=inward" target="_blank">64</a></td></tr></table></div></div></div><div class="foot">Stats last updated on 2020-07-14 01:37:47</div></body></html>